CA Stock MarketDetailed Quotes
ACOG Alpha Cognition Inc
- 0.570
- +0.050+9.62%
15min DelayTrading Oct 18 11:26 ET
85.99MMarket Cap-2780P/E (TTM)
0.570High0.520Low38.12KVolume0.520Open0.520Pre Close20.70KTurnover0.99052wk High0.04%Turnover Ratio150.86MShares0.23052wk Low-0.205EPS TTM62.79MFloat Cap2.490Historical HighLossP/E (Static)110.15MShs Float0.060Historical Low-0.199EPS LYR9.62%Amplitude--Dividend TTM-43.85P/B1Lot Size--Div YieldTTM
About Alpha Cognition Inc Company
Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurological diseases., such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease.
Company Profile
SymbolACOG
Company NameAlpha Cognition Inc
Founded2017
MarketCNQ
Employees4
Fiscal Year Ends12-31
Addressc/o 1200 – 750 West Pender Street
CityVancouver
CountryCAN
Zip CodeV6C 2T8
Phone+1 858 344-4375
Company Executives
- Name
- Position
- Salary
- Michael McFadden
- Chief Executive Officer and Director
- --
- Dr. Denis Kay
- Chief Scientific Officer
- --
- Lauren D’Angelo
- Chief Commercial Officer
- --
- Dr. Cedric O'Gorman, M.D.
- Chief Medical Officer
- --
- Donald Kalkofen
- Chief Financial Officer
- --
- Len Mertz
- Chairman of the Board
- --
- Kenneth A. Cawkell, L.L.B.
- Corporate Secretary and Director
- --
- Phillip Mertz
- Independent Director
- --
- John Havens
- Independent Director
- --
- Rajeev Bakshi
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data